Pyrosequencing-based methods reveal marked inter-individual differences in oncogene mutation burden in human colorectal tumours.
about
Detection of low-abundance KRAS mutations in colorectal cancer using microfluidic capillary electrophoresis-based restriction fragment length polymorphism method with optimized assay conditionsMicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and -independent mechanisms.Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel BiomarkersDown-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancerAlterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancerOpportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.The role of cytology specimens in molecular testing of solid tumors: techniques, limitations, and opportunities.Molecular pathology in lung cancer: a guide to the techniques used in clinical practice.Current companion diagnostics in advanced colorectal cancer; getting a bigger and better piece of the piemiR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor.Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer.MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients.Monitoring the Transcriptional Activity of Human Endogenous Retroviral HERV-W Family Using PNA Strand Invasion into Double-Stranded DNA.Mutant allele frequency predicts the efficacy of EGFR-TKIs in lung adenocarcinoma harboring the L858R mutation.
P2860
Q34565052-E05F6CD0-D841-4EA8-8C52-D9897763609DQ35677921-18C5C318-555B-4090-9B06-37235A2B8673Q35871650-BF55D290-A02F-4833-BC2D-C1ABEE42B9AEQ35998435-05C220F5-1D66-4CAA-B6A5-AC7A27E3D3B0Q36450457-8B31B5D3-C75A-425B-BB81-7878159B9EBDQ36589155-03DC20AB-440F-4196-B100-49E5E547C6B4Q38012417-DF48686B-3765-44FE-9C8D-27A84E978AD1Q38240593-F8D27C2A-57E4-492D-8E1C-CA23AE8838F2Q39172118-0D5B9A62-E496-4DEA-A101-8104070AE348Q44077666-2D3514FA-8CD7-42EA-958C-1FF641B1BEF3Q45376093-8A4F223A-6E4B-4021-8BE9-DB0B33196A65Q45711622-EC96A558-9A9A-420B-80B7-330DAA331AA3Q48291442-89636153-0800-4747-9087-9902A6208747Q51128947-69912CF9-A726-4961-BE9C-30AE64D8A1CC
P2860
Pyrosequencing-based methods reveal marked inter-individual differences in oncogene mutation burden in human colorectal tumours.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pyrosequencing-based methods r ...... n in human colorectal tumours.
@ast
Pyrosequencing-based methods r ...... n in human colorectal tumours.
@en
type
label
Pyrosequencing-based methods r ...... n in human colorectal tumours.
@ast
Pyrosequencing-based methods r ...... n in human colorectal tumours.
@en
prefLabel
Pyrosequencing-based methods r ...... n in human colorectal tumours.
@ast
Pyrosequencing-based methods r ...... n in human colorectal tumours.
@en
P2093
P2860
P356
P1476
Pyrosequencing-based methods r ...... n in human colorectal tumours.
@en
P2093
D Crowther
G Feuerstein
M E Burczynski
R J C Steele
S Weidlich
P2860
P2888
P304
P356
10.1038/BJC.2011.197
P407
P577
2011-06-28T00:00:00Z
P5875
P6179
1000088800